TheraRadar
Clinical-Stage Companies / Handok

Handok

Pre-Approval PRO BETA
33
Total Trials
8
Phase 3
3
Phase 2
0
Recruiting
197
Score

Pipeline by Phase

Phase 3
8
Phase 2
3
Phase 1
16

Therapeutic Focus

Healthy Volunteers Type 2 Diabetes Mellitus Type 2 Diabetes Essential Hypertension P1b: Advanced Solid Tumors

Clinical Trials (33)

NCT05504226 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin 25 mg and Metformin

Started: 10/12/2022

NCT05504239 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of Teneligliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Empaglyflozin and Metformin

Started: 9/27/2022

NCT05476354 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of Irbesartan and Amlodipine Combined Therapy in Essential Hypertension Patients

Started: 7/5/2022

NCT05475665 Phase 3 COMPLETED

Clinical Efficacy and Safety Evaluation of Irbesartan High and Amlodipine Combined Therapy in Essential Hypertension Patients

Started: 7/14/2022

NCT04421911 Phase 3 COMPLETED

A Study to Assess Efficacy and Safety of the Ketoprofen vs Diclofenac

Started: 3/20/2020

NCT02567994 Phase 3 COMPLETED

Tenelia Triple Combination Study

Started: 4/1/2015

NCT01805830 Phase 3 COMPLETED

Teneligliptin(MP-513) vs. Placebo in Patient With Metformin Monotherapy

Started: 5/1/2012

NCT01798238 Phase 3 COMPLETED

Teneligliptin(MP-513) Versus Placebo in Type 2 Diabetes Mellitus

Started: 11/1/2012

NCT04488978 Phase 2 COMPLETED

Phase 2 Study to Evaluate the Efficacy and Safety of Irbesartan and Amlodipine Combined or Alone in Patients With Essential Hypetension

Started: 5/21/2020

NCT02853084 Phase 2 TERMINATED

HL2351 CAPS Phase II Study

Started: 10/1/2015

NCT07102719 Phase 1 COMPLETED

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Started: 9/10/2025

NCT06889350 Phase 1 COMPLETED

Pharmacokinetics and Safety of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Started: 3/26/2025

NCT06339788 Phase 1 COMPLETED

Pharmacokinetics of HD-P023 and Co-administration of Teneligliptin and Empagliflozin High in Healthy Volunteers

Started: 5/10/2024

NCT04492033 Phase 1 TERMINATED

A Study of CTX-009 (ABL001) in Combination With Irinotecan or Paclitaxel in Advanced or Metastatic Solid Tumor Patients

Started: 6/22/2020

NCT05688098 Phase 1 COMPLETED

Pharmacokinetics of Irbesartan/Amlodipine High FDC and Co-administration of Irbesartan and Amlodipine High in Healthy Volunteers

Started: 9/23/2022

NCT05663073 Phase 1 COMPLETED

Pharmacokinetics of Irbesartan/Amlodipine FDC and Co-administration of Irbesartan and Amlodipine in Healthy Volunteers

Started: 9/13/2022

NCT05688085 Phase 1 COMPLETED

Pharmacokinetics of Irbesartan High/Amlodipine FDC and Co-administration of Irbesartan High and Amlodipine in Healthy Volunteers

Started: 10/18/2022

NCT04431141 Phase 1 COMPLETED

Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin

Started: 9/15/2020

NCT04014257 Phase 1 COMPLETED

A Phase 1 Study of NOV1601(CHC2014) in Adult Subjects With Solid Organ Malignancies

Started: 8/9/2019

NCT03769870 Phase 1 COMPLETED

Teneligliptin and Atorvastatin DDI Study

Started: 1/11/2019

NCT03787043 Phase 1 COMPLETED

A Study to Evaluate the Effect of Food on Fixed-Dose Combination of MP-513 10 mg and Metformin XR 750 mg

Started: 5/1/2014

NCT03787017 Phase 1 COMPLETED

A Study to Compare MP-513 20mg & Metformin XR 1000mg FDC With Coadministration of the Two Separate Drugs

Started: 1/1/2014

NCT03009513 Phase 1 COMPLETED

Teneligliptin-Glimepiride DDI Study

Started: 1/1/2017

NCT02175056 Phase 1 COMPLETED

A Dose-Block Randomized, Placebo Controlled (Double-blind), Active Controlled(Open-label), Dose-escalation Study

Started: 5/1/2014

NCT01373398 Phase 1 COMPLETED

Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

Started: 5/1/2011

NCT00934323 Phase 1 COMPLETED

Dose Proportionality Study About Amaryl M Slow Release (SR) 1/500 mg

Started: 10/1/2008

NCT02512523 Phase 4 COMPLETED

Exploratory Study to Compare the Effects of Tenelia® or Januvia® on Glucose Variability in add-on to Metformin (CGMS Study)

Started: 8/27/2015

NCT03508323 Phase 4 COMPLETED

Tenelia Elderly CGMS Study(TEDDY)

Started: 4/3/2018

NCT03011177 Phase 4 COMPLETED

Teneligliptin Versus Linagliptin in Diabetes Mellitus Type Two Patients

Started: 1/1/2017

NCT00913367 Phase 4 COMPLETED

Efficacy/Safety Study of Amaryl®M 1/500 mg Twice Daily Versus Amaryl® 4 mg Both in Combination With Lantus® in Type 2 Diabetes Mellitus

Started: 5/1/2009

NCT01430260 Phase 4 COMPLETED

Omnaris Versus Levocetirizine Phase 4 Study

Started: 1/1/2011

NCT00975065 Phase 4 COMPLETED

Galvus on Met Phase 4 Study : Study to Evaluate the Efficacy and Safety of Early Combination of Vildagliptin and Metformin in Patients With Type 2 Diabetes Mellitus

Started: 8/1/2009

NCT01444248 Phase 4 COMPLETED

Compare the Compliance of Patients Treated With Once-daily (od) or Twice-daily (Bid) Glimepiride and Metformin Fixed Combination Therapy

Started: 8/1/2010

Drug Candidates

HD-P023 Teneligliptin and Empagliflozin Teneligliptin Empagliflozin High Empagliflozin Sitagliptin Teneligliptin (as Teneligliptin Hydrobromide) 20 Mg Oral Tablet Teneligliptin Placebo Oral Tablet CTX-009 (ABL001) Paclitaxel
Activity Status: Active
Last Trial Started: 9/10/2025
Last Trial Ended: 10/20/2025
Trials (12 months): 1
Completed Trials: 31
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.